Business
Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026
BANNOCKBURN, Ill., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, and preliminary financial guidance for the full year 2026. (Year-over-year comparisons unless otherwise noted; Growth comparisons versus midpoint of range) Four
About this update from Option Care Health, Inc.
[{"type":"text","content":"BANNOCKBURN, Ill., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, and preliminary financial guidance for the full year 2026.","length":398,"tagName":"p"},{"type":"text","content":"(Year-over-year comparisons unless otherwise noted; Growth comparisons versus midpoint of range)","length":96,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025 Preliminary Expected Results","length":48,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenue of $1.46 billion to $1.47 billion","length":45,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP net income of $59.1 million to $62.4 million","length":49,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP diluted EPS of $0.37 to $0.39","length":34,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted diluted EPS of $0.46 to $0.49","length":38,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA of $123.7 million to $127.7 million","length":51,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":217,"olType":false},{"type":"text","content":"Full Year 2025 Preliminary Expected Results","length":43,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenue of $5.645 billion to $5.655 billion","length":47,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP net income of $208.2 million to $211.5 million","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP diluted EPS of $1.27 to $1.29","length":34,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted diluted EPS of $1.72 to $1.76","length":38,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA of $469.0 million to $473.0 million","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash flow from operations below $320 million","length":44,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":265,"olType":false},{"type":"text","content":"Full Year 2026 Preliminary Financial Guidance","length":45,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenue of $5.8 billion to $6.0 billion","length":43,...